Direct-to-patient expert system and home INR monitoring improves control of oral anticoagulation

[1]  D. Perry,et al.  Recommendations from the British Committee for Standards in Haematology and National Patient Safety Agency , 2007, British journal of haematology.

[2]  L. Lynd,et al.  Cost-effectiveness of self-managed versus physician-managed oral anticoagulation therapy , 2006, Canadian Medical Association Journal.

[3]  R. Perera,et al.  Self-monitoring of oral anticoagulation: a systematic review and meta-analysis , 2006, The Lancet.

[4]  D. Fitzmaurice,et al.  Self management of oral anticoagulation: randomised trial , 2005, BMJ : British Medical Journal.

[5]  X. Bonfill,et al.  Comparing Self-Management of Oral Anticoagulant Therapy with Clinic Management , 2005, Annals of Internal Medicine.

[6]  T. Ortel.  Clinical implications for patients on antithrombotic therapy while taking supplements. , 2005, Thrombosis research.

[7]  A. Fung,et al.  A randomized trial of patient self-managed versus physician-managed oral anticoagulation. , 2004, The Canadian journal of cardiology.

[8]  D. Fitzmaurice,et al.  Training for patients in a randomised controlled trial of self management of warfarin treatment , 2004, BMJ : British Medical Journal.

[9]  J. Lafata,et al.  Anticoagulation Clinics and Patient Self-Testing for Patients on Chronic Warfarin Therapy: A Cost-Effectiveness Analysis , 2000, Journal of Thrombosis and Thrombolysis.

[10]  Kazutomo Minami,et al.  INR Self-Management Following Mechanical Heart Valve Replacement , 2000, Journal of Thrombosis and Thrombolysis.

[11]  David B. Matchar,et al.  Relationship Between Test Frequency and Outcomes of Anticoagulation: A Literature Review and Commentary with Implications for the Design of Randomized Trials of Patient Self-Management , 2000, Journal of Thrombosis and Thrombolysis.

[12]  D. Horstkotte,et al.  Optimal Frequency of Patient Monitoring and Intensity of Oral Anticoagulation Therapy in Valvular Heart Disease , 2004, Journal of Thrombosis and Thrombolysis.

[13]  F. Rosendaal,et al.  Comparison of the quality of oral anticoagulant therapy through patient self-management and management by specialized anticoagulation clinics in the Netherlands: a randomized clinical trial. , 2003, Archives of internal medicine.

[14]  M. Gent,et al.  Comparison of low-intensity warfarin therapy with conventional-intensity warfarin therapy for long-term prevention of recurrent venous thromboembolism. , 2003, The New England journal of medicine.

[15]  T. Bodenheimer,et al.  Electronic technology: a spark to revitalize primary care? , 2003, JAMA.

[16]  P. Ridker,et al.  Long-term, low-intensity warfarin therapy for the prevention of recurrent venous thromboembolism. , 2003, The New England journal of medicine.

[17]  Enrique J. Gómez,et al.  Telemedicine as a tool for intensive management of diabetes: the DIABTel experience , 2002, Comput. Methods Programs Biomed..

[18]  J. Heit.  Venous Thromboembolism Epidemiology: Implications for Prevention and Management , 2002, Seminars in thrombosis and hemostasis.

[19]  K. Terry.  Monitor patients online? , 2001, Medical economics.

[20]  J. Hirsh,et al.  Managing oral anticoagulant therapy. , 2001, Chest.

[21]  R. Beyth,et al.  A Multicomponent Intervention To Prevent Major Bleeding Complications in Older Patients Receiving Warfarin , 2000, Annals of Internal Medicine.

[22]  M. Prins,et al.  Oral anticoagulation self-management and management by a specialist anticoagulation clinic: a randomised cross-over comparison , 2000, The Lancet.

[23]  A prospective controlled trial comparing weekly self-testing and self-dosing with the standard management of patients on stable oral anticoagulation. , 2000, Thrombosis and haemostasis.

[24]  P. Sawicki,et al.  A structured teaching and self-management program for patients receiving oral anticoagulation: a randomized controlled trial. Working Group for the Study of Patient Self-Management of Oral Anticoagulation. , 1999, JAMA.

[25]  G. Müller‐Berghaus,et al.  State-of-the-Art Patient Self-Management for Control of Oral Anticoagulation , 1999, Seminars in thrombosis and hemostasis.

[26]  J. Harenberg,et al.  The Effect of Self-Monitoring the INR on Quality of Anticoagulation and Quality of Life , 1999, Seminars in thrombosis and hemostasis.

[27]  M G Amato,et al.  Comparison of an anticoagulation clinic with usual medical care: anticoagulation control, patient outcomes, and health care costs. , 1998, Archives of internal medicine.

[28]  W. J. Hamilton,et al.  Adjusted-dose warfarin versus low-intensity, fixed-dose warfarin plus aspirin for high-risk patients with atrial fibrillation: Stroke Prevention in Atrial Fibrillation III randomised clinical trial , 1996, The Lancet.

[29]  S. Fihn,et al.  The Risk for and Severity of Bleeding Complications in Elderly Patients Treated with Warfarin , 1996, Annals of Internal Medicine.

[30]  L. Fish,et al.  Long-term patient self-management of oral anticoagulation. , 1995, Archives of internal medicine.

[31]  B. Gersh,et al.  Bleeding and thromboembolism during anticoagulant therapy: a population-based study in Rochester, Minnesota. , 1995, Mayo Clinic proceedings.

[32]  J. Vandenbroucke,et al.  Optimal oral anticoagulant therapy in patients with mechanical heart valves. , 1995, The New England journal of medicine.

[33]  F R Rosendaal,et al.  A Method to Determine the Optimal Intensity of Oral Anticoagulant Therapy , 1993, Thrombosis and Haemostasis.

[34]  A. Besselaar.  Recommended Method for Reporting Therapeutic Control of Oral Anticoagulant Therapy , 1990 .

[35]  C. Mok,et al.  Warfarin versus dipyridamole-aspirin and pentoxifylline-aspirin for the prevention of prosthetic heart valve thromboembolism: a prospective randomized clinical trial. , 1985, Circulation.

[36]  E. Loeliger.  Laboratory control, optimal therapeutic ranges and therapeutic quality control in oral anticoagulation. , 1985, Acta haematologica.